CITIGROUP INC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 118 filers reported holding VIKING THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,980,606
+18.2%
359,585
+73.1%
0.00%
+50.0%
Q2 2023$3,367,774
-64.2%
207,759
-63.2%
0.00%
-71.4%
Q1 2023$9,407,932
+680.6%
565,041
+340.7%
0.01%
+600.0%
Q4 2022$1,205,174
+7934.5%
128,210
+2261.6%
0.00%
Q3 2022$15,000
+400.0%
5,429
+463.8%
0.00%
Q2 2022$3,000
-81.2%
963
-81.4%
0.00%
Q1 2022$16,000
-98.2%
5,189
-97.2%
0.00%
Q4 2021$867,000
+46.7%
188,459
+100.3%
0.00%
Q3 2021$591,000
-65.9%
94,094
-67.5%
0.00%
-100.0%
Q2 2021$1,732,000
-36.7%
289,165
-33.1%
0.00%
-50.0%
Q1 2021$2,735,000
+427.0%
432,512
+368.9%
0.00%
Q4 2020$519,000
+36.2%
92,236
+41.0%
0.00%
Q3 2020$381,000
-64.5%
65,425
-56.0%
0.00%
Q2 2020$1,072,000
+52.7%
148,806
-0.7%
0.00%
Q1 2020$702,000
-54.1%
149,928
-21.5%
0.00%
-100.0%
Q4 2019$1,531,000
-40.8%
190,992
-49.2%
0.00%
-50.0%
Q3 2019$2,586,000
-51.0%
375,852
-40.9%
0.00%
-50.0%
Q2 2019$5,275,000
+346.7%
635,504
+435.2%
0.00%
+300.0%
Q1 2019$1,181,000
-84.2%
118,737
-87.8%
0.00%
-85.7%
Q4 2018$7,463,000
+15.4%
975,550
+162.7%
0.01%
+40.0%
Q3 2018$6,467,000
+7508.2%
371,309
+4006.0%
0.01%
Q2 2018$85,0009,043
+8943.0%
0.00%
Q1 2016$01000.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders